PROFILE

EDUCATION

2002, PhD in Biological Chemistry, Imperial College London

1997, Laurea in Organic Chemistry, University of Florence, Italy

1989, Scientific Baccalauréat, Collège Stanislas, Paris, France

PROFESSIONAL EXPERIENCE

2021-Present, Chief Scientific Officer, Children's Tumour Foundation Europe

2012-Present, Freelance European Patent Attorney & Life Sciences Consultant

2004-2012, IP Specialist, Siena Biotech

2003-2004, Postdoctoral Researcher, University of Florence

1998-2001, Organic Chemistry Tutor, Imperial College London

RESEARCH ACTIVITIES & OTHERS

1. As part of the EU-PEARL initiative, leading  the drafting of the first EU platform trial protocols for NF1 and NF2.

PUBLICATIONS

1. EU-PEARL Consortium contribution on platform trials state-of-the-art, EClinicalMedicine (2023)

2. Systematic review of neurofibromatosis drug trials, European Journal of Medical Genetics (2021)

3. Neurofibromatosis treatment challenges analysis, European Journal of Human Genetics (2021)

4. Neurofibromatosis as gateway to cancer treatment, Progress in Neurobiology (2017)